Alexa Meara is a Rheumatology/Immunology physician affiliated with The Ohio State University Comprehensive Cancer Center. OpenAlex indexes 115 publications with 2,370 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
44 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
25.1%Corticosteroid23.8%Prednisone100%Part D≥69 patientsSerotonin-3 Receptor Antagonist1.3%Ondansetron Odt100%Part D<11 patientsNervous system
21.1%Gabapentinoids8.5%Gabapentin68%Pregabalin32%Part D<11 patientsOpioid Agonist5.8%Tramadol Hcl100%Part D≥14 patients+ 2 more classes in this area
Antiparasitic
20.9%Antimalarial20.9%Hydroxychloroquine Sulfate100%Part D≥57 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer
2025 - Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis
Cancer Immunology Immunotherapy
2025 - Cardiovascular toxicities associated with bispecific T-cell engager therapy
Journal for ImmunoTherapy of Cancer
2024 - Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets
Seminars in Arthritis and Rheumatism
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Ricardo Carrau, MD
The Ohio State University Comprehensive Cancer Center
Gregory Otterson, MD
The Ohio State University Comprehensive Cancer Center
Steven Clinton, MD, PhD
The Ohio State University Comprehensive Cancer Center
Christian Rolfo, MD
The Ohio State University Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”